Rajagopalan Harith 4

4 · FRACTYL HEALTH, INC. · Filed Feb 3, 2025

Form 4

Period: 2025-01-30

DirectorChief Executive Officer

Transactions

Exercise/Conversion
Stock Option
2025-01-31−90,972→ 11,564 total
Exercise: $1.70Exp: 2025-02-10→ Common Stock (90,972 underlying)
Sale
Common Stock
2025-01-31$1.82/sh−90,972$165,205→ 491,329 total
Exercise/Conversion
Common Stock
2025-01-30$1.70/sh+20,948$35,612→ 512,277 total
Sale
Common Stock
2025-01-30$1.95/sh−20,948$40,798→ 491,329 total
Exercise/Conversion
Common Stock
2025-01-31$1.70/sh+90,972$154,652→ 582,301 total
Exercise/Conversion
Stock Option
2025-01-30−20,948→ 102,536 total
Exercise: $1.70Exp: 2025-02-10→ Common Stock (20,948 underlying)

Holdings

Footnotes (4)

[F1]Represents sales pursuant to a Rule 10b5-1 plan that the Reporting Person entered into on September 12, 2024.
[F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.9100 to $2.0400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.8000 to $1.8800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F4]The option is fully vested and exercisable.

Documents

1 file